We are live on
!
Find out more
AB
Amalgamated Bank Portfolio holdings
AUM
$14.5B
1-Year Est. Return
44.3%
This Fund
S&P 500
This Quarter
Est. Return
-3%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.9B
AUM Growth
-$678M
(-5%)
Cap. Flow
+$6.37M
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
23.8%
Holding
3,083
New
921
Increased
335
Reduced
1,799
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$60.7M |
| 2 |
Medtronic
MDT
|
+$35.8M |
| 3 |
Apple
AAPL
|
+$30.8M |
| 4 |
Microsoft
MSFT
|
+$28.5M |
| 5 |
Linde
LIN
|
+$24.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$21M |
| 2 |
iShares Russell 3000 ETF
IWV
|
+$15.3M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$13.9M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$13.2M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.64% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 13.15% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
PJT Partners
PJT
$4.3B
| $234K | ﹤0.01% |
3,708
-310
| -8% | -$20.2K |
|
1877
REX American Resources
REX
$1.42B
| $234K | ﹤0.01% |
14,094
-852
| -6% | -$13.8K |
|
1878
JFrog
FROG
$9.66B
| $233K | ﹤0.01% |
+8,631
| New | +$218K |
|
|
HTLF
1879
DELISTED
Heartland Financial USA, Inc.
HTLF
| $233K | ﹤0.01% |
4,864
-363
| -7% | -$18.4K |
|
1880
Organogenesis Holdings
ORGO
$305M
| $232K | ﹤0.01% |
30,462
+2,293
| +8% | +$17.7K |
|
1881
RE/MAX Holdings
RMAX
$193M
| $232K | ﹤0.01% |
8,366
-498
| -6% | -$14.7K |
|
|
FLNA
1882
Filana Therapeutics
FLNA
$48.8M
| $232K | ﹤0.01% |
6,239
-495
| -7% | -$21K |
|
|
HTO
1883
H2O America
HTO
$2.57B
| $232K | ﹤0.01% |
3,339
-249
| -7% | -$16.8K |
|
1884
SkinHealth Systems
SKIN
$88.8M
| $232K | ﹤0.01% |
13,731
-1,138
| -8% | -$18.8K |
|
|
TVRD
1885
Tvardi Therapeutics
TVRD
$19.7M
| $232K | ﹤0.01% |
530
-32
| -6% | -$13.1K |
|
|
CERE
1886
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $232K | ﹤0.01% |
6,633
-497
| -7% | -$14.5K |
|
1887
CryoPort
CYRX
$761M
| $231K | ﹤0.01% |
6,614
-525
| -7% | -$19.8K |
|
1888
Domo
DOMO
$174M
| $231K | ﹤0.01% |
4,572
-337
| -7% | -$15.3K |
|
1889
Schneider National
SNDR
$6.26B
| $231K | ﹤0.01% |
9,047
-342
| -4% | -$8.9K |
|
|
SILK
1890
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $231K | ﹤0.01% |
5,599
-423
| -7% | -$14.9K |
|
1891
Gray Television
GTN
$415M
| $228K | ﹤0.01% |
10,312
-768
| -7% | -$16.9K |
|
|
HEES
1892
DELISTED
H&E Equipment Services
HEES
| $228K | ﹤0.01% |
5,244
-435
| -8% | -$18.3K |
|
|
TGH
1893
DELISTED
Textainer Group Holdings limited
TGH
| $227K | ﹤0.01% |
5,957
-492
| -8% | -$18.6K |
|
|
ONT
1894
Onterris Inc
ONT
$759M
| $226K | ﹤0.01% |
4,270
-333
| -7% | -$16.5K |
|
1895
HCI Group
HCI
$2.23B
| $224K | ﹤0.01% |
3,282
-177
| -5% | -$12.1K |
|
1896
HealthStream
HSTM
$819M
| $224K | ﹤0.01% |
11,247
-678
| -6% | -$15.3K |
|
1897
LegalZoom.com
LZ
$1.35B
| $224K | ﹤0.01% |
+15,818
| New | +$238K |
|
1898
Veracyte
VCYT
$3.7B
| $224K | ﹤0.01% |
8,140
-606
| -7% | -$17.3K |
|
1899
Health Catalyst
HCAT
$154M
| $223K | ﹤0.01% |
8,526
-558
| -6% | -$15.8K |
|
|
TBRG
1900
DELISTED
TruBridge
TBRG
| $223K | ﹤0.01% |
6,463
-364
| -5% | -$11.1K |
|
Similar funds
JFG
IFP
BBVA
SSA
BGC
FGP
Amalgamated Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Amalgamated Bank held 3,083 positions worth $12.9B, down 5% from $13.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Amalgamated Bank's Q1 2022 filing shows 921 new, 335 increased, 1,799 reduced and 24 closed positions. Its largest new stake was Accenture: 180,111 shares worth $60.7M. The largest sale was iShares Core S&P 500 ETF, an estimated $21M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Amalgamated Bank's largest Q1 2022 buy was Accenture: 180,111 shares worth $60.7M.
- Amalgamated Bank added most to Apple in Q1 2022, an estimated $30.8M increase.
- Amalgamated Bank's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21M.
- Amalgamated Bank fully exited iShares Russell 3000 ETF in Q1 2022, selling an estimated $15.3M.
- Amalgamated Bank's ten largest holdings make up 24% of its $12.9B portfolio in Q1 2022.
- Amalgamated Bank opened 921 new positions and closed 24 in Q1 2022.
- Amalgamated Bank's portfolio value fell 5% quarter-over-quarter to $12.9B.
Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.